Kiniksa Pharmaceuticals International (KNSA) earnings per share (EPS)

Earnings per share · fiscal 2025
$0.75

Kiniksa Pharmaceuticals International (KNSA) reported diluted earnings per share of $0.75 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$0.60. Figures as of 17 Nov 2026, 21:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$0.75
Highest on record
$2.60fiscal 2022
Lowest on record
-$2.99fiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Kiniksa Pharmaceuticals International earnings per share (EPS), in more detail

Across the 7 fiscal years on record (2019–2025), the highest was $2.60 in fiscal 2022 and the lowest -$2.99 in fiscal 2019.

History · 7 fiscal years

Earnings per share by fiscal year

Kiniksa Pharmaceuticals International earnings per share (EPS), year by year

Kiniksa Pharmaceuticals International (KNSA) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$0.75—
2024-$0.60 400.0% down
2023$0.20 92.3% down
2022$2.60—
2021-$2.30—
2020-$2.61—
2019-$2.99—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Kiniksa Pharmaceuticals International and comparable companies
CompanyEarnings per shareFiscal year
Alkermes ALKS$1.432025
Kiniksa Pharmaceuticals International KNSA$0.752025
ImmunityBio IBRX-$0.382025
ABIVAX ABVX-€4.832025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KNSA

Kiniksa Pharmaceuticals International, figure by figure

Kiniksa Pharmaceuticals International (KNSA) overview: price, valuation and scorecardAll health care companies by market value

Kiniksa Pharmaceuticals International earnings per share (EPS): questions and answers

What is Kiniksa Pharmaceuticals International's diluted earnings per share?

Kiniksa Pharmaceuticals International (KNSA) reported diluted earnings per share of $0.75 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$0.60.

What are the highest and lowest diluted earnings per share figures on record for Kiniksa Pharmaceuticals International?

Across the 7 fiscal years on record (2019–2025), the highest was $2.60 in fiscal 2022 and the lowest -$2.99 in fiscal 2019.

How is Kiniksa Pharmaceuticals International's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kiniksa Pharmaceuticals International (KNSA) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/KNSA/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.